France Brachytherapy Market Size, Share, and COVID-19 Impact Analysis, By Product (Seeds, Electronic Brachytherapy, Applicators & Afterloaders), By Application (Prostate Cancer, Breast Cancer), France Brachytherapy Market Insights, Industry Trend, Forecasts to 2035

France Brachytherapy Market Insights Forecasts to 2035 

• The France Brachytherapy Market Size was Estimated at USD 31.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.63% from 2025 to 2035
• The France Brachytherapy Market Size is Expected to Reach USD 71.6 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the France Brachytherapy Market Size is Anticipated to Reach USD 71.6 Million by 2035, Growing at a CAGR of 7.63% from 2025 to 2035. This is because the market is anticipated to grow during the forecast period due to factors such as the rising incidence of cancer, technological developments, and a notable increase in the use of brachytherapy.

Market Overview 

The market for brachytherapy services and equipment in France is known as the French brachytherapy market.  To deliver targeted radiation, radioactive sources are positioned inside or close to the tumor in a procedure known as brachytherapy.  This market covers both the supply of brachytherapy services in hospitals and specialty clinics, as well as the sale and distribution of brachytherapy equipment (such as applicators, afterloaders, and seeds). The market is anticipated to grow during the forecast period due to a number of factors, including rising cancer prevalence, technological advancements, and a notable increase in the use of brachytherapy.  One kind of radiation therapy used to treat cancer is called brachytherapy.  Catheters are used to introduce radioactive materials into the body.  It is a great way to treat localized tumors. Radionuclides like Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103 are frequently produced artificially.

Report Coverage

This research report categorizes the France brachytherapy market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France brachytherapy market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France brachytherapy market.

Driving Factors

The France brachytherapy market is driven by the fact that radiation therapy can be curative, palliative, or preventive.  Additionally, it can be used alone or in conjunction with immunotherapy, chemotherapy, and surgery as an adjuvant.  Physicians are using radiotherapy more frequently because of its many uses.  Recent developments in radiation therapy make it possible to deliver a high dose to the target area while causing the least amount of harm to the healthy tissues nearby.  Radiation therapy has become more in demand as a result of improved cure rates and increased chances of localized tumor control.

Restraining Factors

A decrease in the number of brachytherapy facilities, antiquated coding schemes, and reimbursement problems that fail to appropriately take procedure complexity into account are some of the difficulties facing the French brachytherapy market.  

Market Segmentation

The France brachytherapy market share is classified into product and application.

• The applicators & afterloaders segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France brachytherapy market is segmented by product into seeds, electronic brachytherapy, applicators & afterloaders. Among these, the applicators & afterloaders segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because these are less invasive and more effective than others; applicators have a high degree of patient preference. An apparatus known as an afterloader is used to move the radioactive sources to the treatment location.  One radioactive source is briefly placed inside the tumor and then removed during HDR brachytherapy.

• The prostate cancer segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France brachytherapy market is segmented by application into prostate cancer, breast cancer. Among these, the prostate cancer segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to a number of benefits over alternative forms of treatment, and the prostate cancer brachytherapy market is anticipated to expand at a profitable rate.  These benefits include a shorter treatment duration, a quicker recovery, a lower risk of side effects because of the precise and accurate radiation dose delivery, an effective treatment for patients with prostate cancer recurrence, and the ability to safely increase the dose to the tumor while minimizing the dose to the surrounding organs, such as the rectum, bladder, and urethra.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France brachytherapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Becton
• Dickinson & Company
• Elekta AB
• Isoray Medical, Inc.
• Theragenics Corporation
• Eckert & Ziegler BEBIG
• Varian Medical Systems, Inc.
• iCAD, Inc.
• CIVCO Medical Solutions
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Brachytherapy Market based on the below-mentioned segments:

France Brachytherapy Market, By Product                                                                          

• Seeds
• Electronic Brachytherapy
• Applicators & Afterloaders

France Brachytherapy Market, By Application                                                  

• Prostate Cancer
• Breast Cancer